1. Home
  2. KMDA vs SAR Comparison

KMDA vs SAR Comparison

Compare KMDA & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • SAR
  • Stock Information
  • Founded
  • KMDA 1990
  • SAR 2007
  • Country
  • KMDA Israel
  • SAR United States
  • Employees
  • KMDA N/A
  • SAR N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • SAR Investment Managers
  • Sector
  • KMDA Health Care
  • SAR Finance
  • Exchange
  • KMDA Nasdaq
  • SAR Nasdaq
  • Market Cap
  • KMDA 349.1M
  • SAR 309.4M
  • IPO Year
  • KMDA N/A
  • SAR 2007
  • Fundamental
  • Price
  • KMDA $6.47
  • SAR $23.58
  • Analyst Decision
  • KMDA Strong Buy
  • SAR Buy
  • Analyst Count
  • KMDA 3
  • SAR 4
  • Target Price
  • KMDA $14.67
  • SAR $25.08
  • AVG Volume (30 Days)
  • KMDA 106.2K
  • SAR 97.1K
  • Earning Date
  • KMDA 05-07-2025
  • SAR 05-07-2025
  • Dividend Yield
  • KMDA 3.10%
  • SAR 14.12%
  • EPS Growth
  • KMDA 66.67
  • SAR 33.28
  • EPS
  • KMDA 0.25
  • SAR 2.49
  • Revenue
  • KMDA $160,953,000.00
  • SAR $154,793,533.00
  • Revenue This Year
  • KMDA $14.01
  • SAR $6.07
  • Revenue Next Year
  • KMDA $9.24
  • SAR N/A
  • P/E Ratio
  • KMDA $25.58
  • SAR $9.46
  • Revenue Growth
  • KMDA 12.93
  • SAR 11.52
  • 52 Week Low
  • KMDA $4.74
  • SAR $21.10
  • 52 Week High
  • KMDA $9.15
  • SAR $26.49
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 49.43
  • SAR 48.67
  • Support Level
  • KMDA $6.36
  • SAR $22.60
  • Resistance Level
  • KMDA $6.57
  • SAR $23.54
  • Average True Range (ATR)
  • KMDA 0.28
  • SAR 0.92
  • MACD
  • KMDA 0.06
  • SAR 0.05
  • Stochastic Oscillator
  • KMDA 76.23
  • SAR 57.01

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: